Literature DB >> 14967843

Evidence for a gene on chromosome 13 influencing postural systolic blood pressure change and body mass index.

Kari E North1, Kathryn M Rose, Ingrid B Borecki, Albert Oberman, Steven C Hunt, Michael B Miller, John Blangero, Laura Almasy, James S Pankow.   

Abstract

Previous analysis in the Hypertension Genetic Epidemiology Network (HyperGEN) of the National Heart Lung and Blood Institute (NHLBI) Family Blood Pressure Program, a multicenter study of genetic and environmental factors related to hypertension, indicated regions of linkage for blood pressure traits together with several coincident regions for phenotypically correlated traits, including systolic blood pressure (SBP) response to a postural challenge and body mass index (BMI). Motivated by these findings and by our desire to better understand the physiology of these traits, we conducted bivariate linkage analysis of postural SBP change and BMI. Sibships in HyperGEN were recruited from 5 field centers in Massachusetts, North Carolina, Minnesota, Utah, and Alabama. All available affected siblings, their parents, and selected nonmedicated offspring were recruited. Among 1636 whites and 1747 blacks, we performed a maximum likelihood bivariate genome scan for quantitative trait loci influencing postural SBP change and BMI, similarly adjusted for race, study center, sex, age, and age-by-sex interactions. Genome scans were performed using SOLAR (version 2.0) and race-specific marker allele frequencies derived from founders. The maximum genome-wide logarithm of odds (LOD) score of 3.2 was detected on chromosome 13 at 24 cM. This marker (D13S493) lies within 20 cM of a marker previously linked to BMI in the Family Heart Study and is substantially higher than the univariate linkage for each trait (LOD scores for BMI and postural SBP change were 2.4 and 0.9, respectively). These findings suggest that a gene(s) on chromosome 13q jointly regulates the SBP response to postural change and BMI.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14967843     DOI: 10.1161/01.HYP.0000118921.66329.da

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  5 in total

1.  Postural changes in blood pressure associated with interactions between candidate genes for chronic respiratory diseases and exposure to particulate matter.

Authors:  Elissa Wilker; Murray A Mittleman; Augusto A Litonjua; Audrey Poon; Andrea Baccarelli; Helen Suh; Robert O Wright; David Sparrow; Pantel Vokonas; Joel Schwartz
Journal:  Environ Health Perspect       Date:  2009-02-03       Impact factor: 9.031

2.  The C-1021T polymorphism of dopamine β-hydroxylase is not associated with orthostatic hypotension in a Chinese population.

Authors:  N Lu; J Chen; Y Yuan; X Cong; Y Yang; L Meng; K Sun; R Hui; Y Zheng
Journal:  J Hum Hypertens       Date:  2014-07-03       Impact factor: 3.012

3.  Polymorphisms of angiotensin-converting enzyme (ACE) and ACE2 are not associated with orthostatic blood pressure dysregulation in hypertensive patients.

Authors:  Xiao-han Fan; Yi-bo Wang; Hu Wang; Kai Sun; Wei-li Zhang; Xiao-dong Song; Jing-zhou Cheng; Hai-ying Wu; Xiang-liang Zhou; Ru-tai Hui
Journal:  Acta Pharmacol Sin       Date:  2009-08-17       Impact factor: 6.150

4.  Orthostatic hypotension and novel blood pressure-associated gene variants: Genetics of Postural Hemodynamics (GPH) Consortium.

Authors:  Artur Fedorowski; Nora Franceschini; Jennifer Brody; Chunyu Liu; Germaine C Verwoert; Eric Boerwinkle; David Couper; Kenneth M Rice; Jerome I Rotter; Francesco Mattace-Raso; Andre Uitterlinden; Albert Hofman; Peter Almgren; Marketa Sjögren; Bo Hedblad; Martin G Larson; Christopher Newton-Cheh; Thomas J Wang; Kathryn M Rose; Bruce M Psaty; Daniel Levy; Jacqueline Witteman; Olle Melander
Journal:  Eur Heart J       Date:  2012-04-14       Impact factor: 29.983

5.  Orthostatic blood pressure dysregulation and polymorphisms of β-adrenergic receptor genes in hypertensive patients.

Authors:  Ying Gao; Yahui Lin; Kai Sun; Yibo Wang; Jingzhou Chen; Hu Wang; Xianliang Zhou; Xiaohan Fan; Rutai Hui
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-02-19       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.